Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Medivir

- PMLiVE

Merck KGaA exec takes top job at UK biotech Kymab

UK biotech veteran returns to head antibody specialist

- PMLiVE

Investments show UK biotech still booming despite Brexit

UK raised a quarter of all European biotech funds

- PMLiVE

Novartis and Syncona back new Swiss biotech Anaveon

Founders focused on IL-2 Receptor Agonists

- PMLiVE

Ex-Pharmacyclics CEO invests $25m in Summit

After Duchenne drug failure, UK biotech looks to new anti-infective

- PMLiVE

New leader at Medivir after setbacks

Christine Lind departs Swedish biotech

- PMLiVE

Orchard plans IPO as gene therapy pipeline advances

UK biotech seeks funds for expanded rare disease portfolio

- PMLiVE

Abingworth raises $315m to expand hunt for promising biotechs

New fund earmarked for early to late-stage European and US firms

- PMLiVE

Sanofi’s rare blood disorder drug Cablivi set for European approval

Rare disease drug among notable CHMP recommendations

- PMLiVE

Daily Brief: Charity criticises NHSE and Vertex over Orkambi access, Sema scores again, NodThera launched

The latest from pharma, biotech and healthcare

- PMLiVE

Paris biocluster appoints Stéphane Roques as new chief

Former general manager for Emmanuel Macron's party to spearhead Paris' bid to attract life sciences investment

- PMLiVE

Daily Brief: EULAR kicks off, Brexit lurches closer and Autolus prepares for IPO

A rapid round up of today's pharma, biotech and healthcare news

- PMLiVE

Jim Mellon’s biotech Juvenescence raises $50m for anti-ageing therapies

Billionaire's belief in emerging anti-ageing therapies fuels start up

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links